|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:HCFC1-EPHA5 (FusionGDB2 ID:35596) |
Fusion Gene Summary for HCFC1-EPHA5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: HCFC1-EPHA5 | Fusion gene ID: 35596 | Hgene | Tgene | Gene symbol | HCFC1 | EPHA5 | Gene ID | 3054 | 2044 |
Gene name | host cell factor C1 | EPH receptor A5 | |
Synonyms | CFF|HCF|HCF-1|HCF1|HFC1|MRX3|PPP1R89|VCAF | CEK7|EHK-1|EHK1|EK7|HEK7|TYRO4 | |
Cytomap | Xq28 | 4q13.1-q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | host cell factor 1VP16-accessory proteinprotein phosphatase 1, regulatory subunit 89 | ephrin type-A receptor 5EPH homology kinase 1EPH-like kinase 7brain-specific kinaseepididymis secretory sperm binding proteinreceptor protein-tyrosine kinase HEK7tyrosine-protein kinase receptor EHK-1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P51610 | P54756 | |
Ensembl transtripts involved in fusion gene | ENST00000310441, ENST00000369984, ENST00000354233, ENST00000461098, | ENST00000273854, ENST00000432638, ENST00000354839, ENST00000511294, | |
Fusion gene scores | * DoF score | 16 X 17 X 8=2176 | 6 X 5 X 3=90 |
# samples | 25 | 5 | |
** MAII score | log2(25/2176*10)=-3.12167855658825 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/90*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: HCFC1 [Title/Abstract] AND EPHA5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | HCFC1(153236099)-EPHA5(66189937), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | HCFC1-EPHA5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. HCFC1-EPHA5 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. HCFC1-EPHA5 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. HCFC1-EPHA5 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | HCFC1 | GO:0006355 | regulation of transcription, DNA-templated | 12670868 |
Hgene | HCFC1 | GO:0010628 | positive regulation of gene expression | 21285374 |
Hgene | HCFC1 | GO:0043254 | regulation of protein complex assembly | 10675337 |
Hgene | HCFC1 | GO:0043981 | histone H4-K5 acetylation | 20018852 |
Hgene | HCFC1 | GO:0043982 | histone H4-K8 acetylation | 20018852 |
Hgene | HCFC1 | GO:0043984 | histone H4-K16 acetylation | 20018852 |
Hgene | HCFC1 | GO:0050821 | protein stabilization | 21285374 |
Fusion gene breakpoints across HCFC1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across EPHA5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-LA-A446-01A | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
ChimerDB4 | LUSC | TCGA-LA-A446 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
ChimerDB4 | LUSC | TCGA-LA-A446-01A | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
Top |
Fusion Gene ORF analysis for HCFC1-EPHA5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000310441 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
Frame-shift | ENST00000310441 | ENST00000432638 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
In-frame | ENST00000310441 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
5CDS-intron | ENST00000310441 | ENST00000511294 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
In-frame | ENST00000369984 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
Frame-shift | ENST00000369984 | ENST00000432638 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
In-frame | ENST00000369984 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
5CDS-intron | ENST00000369984 | ENST00000511294 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
In-frame | ENST00000354233 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
Frame-shift | ENST00000354233 | ENST00000432638 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
In-frame | ENST00000354233 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
5CDS-intron | ENST00000354233 | ENST00000511294 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
intron-3CDS | ENST00000461098 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
intron-3CDS | ENST00000461098 | ENST00000432638 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
intron-3CDS | ENST00000461098 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
intron-intron | ENST00000461098 | ENST00000511294 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000310441 | HCFC1 | chrX | 153236099 | - | ENST00000273854 | EPHA5 | chr4 | 66189937 | - | 5817 | 1160 | 1014 | 406 | 202 |
ENST00000310441 | HCFC1 | chrX | 153236099 | - | ENST00000354839 | EPHA5 | chr4 | 66189937 | - | 1452 | 1160 | 1014 | 406 | 202 |
ENST00000369984 | HCFC1 | chrX | 153236099 | - | ENST00000273854 | EPHA5 | chr4 | 66189937 | - | 5194 | 537 | 648 | 259 | 129 |
ENST00000369984 | HCFC1 | chrX | 153236099 | - | ENST00000354839 | EPHA5 | chr4 | 66189937 | - | 829 | 537 | 648 | 259 | 129 |
ENST00000354233 | HCFC1 | chrX | 153236099 | - | ENST00000273854 | EPHA5 | chr4 | 66189937 | - | 5378 | 721 | 832 | 443 | 129 |
ENST00000354233 | HCFC1 | chrX | 153236099 | - | ENST00000354839 | EPHA5 | chr4 | 66189937 | - | 1013 | 721 | 832 | 443 | 129 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000310441 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.79326963 | 0.20673038 |
ENST00000310441 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.44918746 | 0.5508126 |
ENST00000369984 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.8026404 | 0.1973596 |
ENST00000369984 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.46355402 | 0.536446 |
ENST00000354233 | ENST00000273854 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.79764384 | 0.20235611 |
ENST00000354233 | ENST00000354839 | HCFC1 | chrX | 153236099 | - | EPHA5 | chr4 | 66189937 | - | 0.43971318 | 0.5602869 |
Top |
Fusion Genomic Features for HCFC1-EPHA5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for HCFC1-EPHA5 |
Go to FGviewer for the breakpoints of chrX:153236099-chr4:66189937 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
HCFC1 | EPHA5 |
FUNCTION: Involved in control of the cell cycle (PubMed:10629049, PubMed:10779346, PubMed:15190068, PubMed:16624878, PubMed:23629655). Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 (PubMed:10675337, PubMed:12244100). Coactivator for EGR2 and GABP2 (PubMed:12244100, PubMed:14532282). Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription, respectively) together (PubMed:12670868). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 (PubMed:20200153). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition (PubMed:23629655). {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:10675337, ECO:0000269|PubMed:10779346, ECO:0000269|PubMed:12244100, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:14532282, ECO:0000269|PubMed:15190068, ECO:0000269|PubMed:16624878, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:23629655}.; FUNCTION: (Microbial infection) In case of human herpes simplex virus (HSV) infection, HCFC1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and POU2F1 thereby enabling the transcription of the viral immediate early genes. {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:17578910}. | FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino-hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. In addition to its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 1035_1037 | 1002.6666666666666 | 1038.0 | Motif | PDZ-binding | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 1035_1037 | 980.6666666666666 | 1016.0 | Motif | PDZ-binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1797_1888 | 64.33333333333333 | 2036.0 | Domain | Fibronectin type-III 2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1890_2006 | 64.33333333333333 | 2036.0 | Domain | Fibronectin type-III 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 366_466 | 64.33333333333333 | 2036.0 | Domain | Fibronectin type-III 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1797_1888 | 64.33333333333333 | 1967.0 | Domain | Fibronectin type-III 2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1890_2006 | 64.33333333333333 | 1967.0 | Domain | Fibronectin type-III 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 366_466 | 64.33333333333333 | 1967.0 | Domain | Fibronectin type-III 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1010_1035 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1072_1097 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1101_1126 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1158_1183 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 4%3B degenerate |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1286_1311 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 5 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1314_1339 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 6 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1349_1374 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 7%3B degenerate |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 1414_1439 | 64.33333333333333 | 2036.0 | Repeat | Note=HCF repeat 8 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 148_194 | 64.33333333333333 | 2036.0 | Repeat | Note=Kelch 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 217_265 | 64.33333333333333 | 2036.0 | Repeat | Note=Kelch 4 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 266_313 | 64.33333333333333 | 2036.0 | Repeat | Note=Kelch 5 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 44_89 | 64.33333333333333 | 2036.0 | Repeat | Note=Kelch 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 93_140 | 64.33333333333333 | 2036.0 | Repeat | Note=Kelch 2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1010_1035 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1072_1097 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1101_1126 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1158_1183 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 4%3B degenerate |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1286_1311 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 5 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1314_1339 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 6 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1349_1374 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 7%3B degenerate |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 1414_1439 | 64.33333333333333 | 1967.0 | Repeat | Note=HCF repeat 8 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 148_194 | 64.33333333333333 | 1967.0 | Repeat | Note=Kelch 3 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 217_265 | 64.33333333333333 | 1967.0 | Repeat | Note=Kelch 4 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 266_313 | 64.33333333333333 | 1967.0 | Repeat | Note=Kelch 5 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 44_89 | 64.33333333333333 | 1967.0 | Repeat | Note=Kelch 1 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 93_140 | 64.33333333333333 | 1967.0 | Repeat | Note=Kelch 2 |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 220_354 | 1002.6666666666666 | 1038.0 | Compositional bias | Note=Cys-rich | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 220_354 | 980.6666666666666 | 1016.0 | Compositional bias | Note=Cys-rich | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 357_467 | 1002.6666666666666 | 1038.0 | Domain | Fibronectin type-III 1 | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 468_562 | 1002.6666666666666 | 1038.0 | Domain | Fibronectin type-III 2 | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 60_238 | 1002.6666666666666 | 1038.0 | Domain | Eph LBD | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 675_936 | 1002.6666666666666 | 1038.0 | Domain | Protein kinase | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 965_1029 | 1002.6666666666666 | 1038.0 | Domain | SAM | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 357_467 | 980.6666666666666 | 1016.0 | Domain | Fibronectin type-III 1 | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 468_562 | 980.6666666666666 | 1016.0 | Domain | Fibronectin type-III 2 | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 60_238 | 980.6666666666666 | 1016.0 | Domain | Eph LBD | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 675_936 | 980.6666666666666 | 1016.0 | Domain | Protein kinase | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 965_1029 | 980.6666666666666 | 1016.0 | Domain | SAM | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 681_689 | 1002.6666666666666 | 1038.0 | Nucleotide binding | ATP | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 681_689 | 980.6666666666666 | 1016.0 | Nucleotide binding | ATP | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 25_573 | 1002.6666666666666 | 1038.0 | Topological domain | Extracellular | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 595_1037 | 1002.6666666666666 | 1038.0 | Topological domain | Cytoplasmic | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 25_573 | 980.6666666666666 | 1016.0 | Topological domain | Extracellular | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 595_1037 | 980.6666666666666 | 1016.0 | Topological domain | Cytoplasmic | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000273854 | 16 | 18 | 574_594 | 1002.6666666666666 | 1038.0 | Transmembrane | Helical | |
Tgene | EPHA5 | chrX:153236099 | chr4:66189937 | ENST00000354839 | 15 | 17 | 574_594 | 980.6666666666666 | 1016.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for HCFC1-EPHA5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000310441_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=5817nt_BP=1160nt CGGCTCCCAGGGAGGAGGCATGAGCGCCCTGCCGTTACCGCTTCTTCTGCCGTACAGTTGCCGCTTCGGGGCCTAACTCTAGCTCTTTGA AGCGGCTCCTGTGGGAAGGAGTCATAAGGCGGGAAGTGAGGATCGGACACCGCCTTGAGTTTGGTGTGCAGTGGAAGAACTGACCTAGGA GGAAGAGAATAGGGGGGAACGGGGAGCTAGTCTCAAGATGGCGGCTCCCACGGCGGCAGGCGCAGCCTGAGCAGCAGAGGCGGACTAAGG GGAGAGGCGCGAGACTTCACAAGCCGTACGGCGCGAGCCCCCAAACGGCCCTCGAGAGCTCGAGCTGGTTCCACCGGCCTCCGGCCCGCC TCCATTCGTTAGGTGTGTCGAGGCTGTTTCGGGAGCGGCGGCTGCACTAAGGCGCTGGGCGGGGAAGCGGGACGGTCTCAAGATGGCGGC TCCCACAATTGTGGTCTGAGCGCCGGCGGGGCTGCGACGACCGCGGCGCTTGTGGCTCCTTTCCACCCGCCCCGGAAGCCGGCCAGTGCT GGGGACTTGGGGGTGTGGGAACCGGGCCGGGGCTCCGCCATTTCCGGCGGGGGAGGGCTACGACTGAGGAAGGGAGGAGAGAGAGGCGGC TCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACTCAGCGGCCTCC AGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCAAAGGGAAGGAG GGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACGAAAGGGGGTGT GTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCCGTGTCGCCCGC CAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCACGGCCACCGCGC CGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACGGGGATTTGAGA CGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACGGAATGGTGCCA TTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAAAAAAAGGGGGA AAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGTATCCAGTTCTT AGTCCTTAGTCTTCATTTTTCATGAAGCAAACATATCTTGCATTAAAAGGGACATGAAGTTAGACATCATCTTAAGTTACAACAACAGAA TCCTTCCCACTACTTCTACAAAATTTTGTACATGAAATATATAATTATATAGCACTTTTATAGACTGAATTAAGGCAACCCCTTTCAAAA CTTCCAGGGATCTACTTGAAAGGAAATGTTTTATAGCCATTTGTGAGCTAACAAAAGCTACAGTTTACTGAAGTTTACTTCAAGTCTTAA TTGTCTACAAAAGTGTATTGAAGAGCAATATGATTAGATTATTTCTTAATAGATATCTTCTTTTGTAATTTTAAAATGCTGTTACACAGC GTTAAGTTATAGAAACTAGTGTGTAAACATGTTGCTTGATCAAGAAAAAGTACAATACAGGGTGTATATTTATTTTTTGTGTTATAAAGT TTACTTTTAGTTGCTCTTCTAGAGATTATTAGGTAATAAATGTGTATATACTGTATAATTTGCAATATACCCAGGAACTGATTTAAGATG GAATTGTGTGTGTGTTTGCTTGCACATGTGTGTGTTACCATTCTGCTTGCATTTCTAATAGTGTTTCAATTTTAGCAACATATAGGAGCA AGTGTTCCAGAATGTAATATGAATAGGAGAAATAGGGAAGCAGTAAAACAAAATTTAACACAAGCTTGTGTCTCTTTTCCTCTCATGTGT CCAAAAGCTAATCTCTTTATTCACTAAAAGGAAATGTGTATAAGACTAAATCCCCTTTGGCTTTTTAAAAACATTTTGTGATATCAGTGA CAATGCAGTTCTTCTAGCCATTAATCTTGTACCCCTGTAAGAAATTTCACCTTTCTGAGTCCTGAAAAGTATCTTGTCAAGCAAAGTTGA CACCGAAGGGCACATTTTCAGCAGGATGTAGAAGGATTTAACTGTGCAGGCTTCTGTTAATGTTGTTAAATCCAGGCACATAGCACGAAG CATCACCCTTAAGTGTTAATCCGTTGTAACCATTCCCATTTTGACTCAGTTCTAGAAATTTTGACTCTAAGGCAGCAATGGAATTATGAC AAATATATATATATACACATACACACACACAAATATATATATATGCTTATTTCCCTTCAGAATTTTATTTCAATAATTGATAAGTTTTAT TTTTAATGGATGTTTATTCATTTGTTAATTTCAGTTTGTATTCAGTTACATGGCTTTGAGTTTATTTTATTGAACCAATCCAAGGTATTA TGTAATTAGGCTTATTAAGGAATATAACATATCTTCTATGTATGCTCTATATACCACACATGATGAAGACTTATATTTGTGATACAAATT ATGCAGTGTATTAGAAATTGTCCAAAACTGAGCTCCTGAGATAACCAACATTTTTGTATTATTACACTTTATAAAAATTATGGAATGTCA TGTGATTAGTCAAAATCAGAGCATTTAAATAAAATACAGCCTACTCATGATTATCAATGTTAATAGTACAGTAGATCAGAGAAGCCTGGA TTAATGAAATTTATCAGAAATATAGCCACGTTATATTAATGGTATTCTTTTTTCCAAGCACTTGTTTTATTTGAATATTAGCACATATAA GAATAAACTTTTGGGAAATAACTACTTCCTATTCTGCCCACCCTTTACTTAAGCAGTAAAGTACCTCTTTTCTAAAGAACCAGGAAACAT CAAAATAACCACAACAAAAATCTAAACAGTTTTCAAATAATACATTCAGTTCTCATAATAATAAGGGCTATATACCATGGGTCCACACAA ACTGTGCTGCAAACATATAATCTATTAGTTTAGTAAAATTTCCAGAGATGTGAATTTAATATTTTCTTGATAAAATCATAAAAAAGCATC ACCATTATTAAAGATGCATTTGTTCATTTCAATAAACAGAAATTAATGAAACAAATTACTTTTGTACAAAATAAATGATGATTATGTGGC ACTTTATTGAATTTTATAGAAATATTCCAATCTAAGTGATAAAGTAACAACTGAGAAACTTCAGAATGAAAGCCTTATTGATTCAAAAGG AAAATTACCATATGCTTTAGGGCTGATGAACTTGCCACAATTGCTTAGACATAACAAAGATATTTTCTACATTGTTTTCCAACTTTATAT GCTGAAAGATAATTAGGAGGTCCGGGTGGAGTGTATCTAAATGACTAGAACTTTAAGTTGCAATATAGATTTTCTCTTTTTAACAAAGGA AGAATATAAATTAATTTGGATCAAATTTATTTGCCTTCTTTGCAATCTTGGTGATCATTTTGGAAAGTAAATTGAAAGGAAAGTTAAATA GCCACATAGTTTTCTTTTGCATCTCAATTTGGTTGAGAATTTCTAAGGAAGGTTAATATGACTTTAGAATGAATAAAGAGACTGTCAAAC AACAAGTACTCTCCCTAAAAAAGAGGAAAGAATGCCTTCCTAAAATATTTGTTTCCTATTGTATATGTCACCAATTGGAAAATGCCAATC TCATCTGCAAGTGTGAGAAATGGAACAAGGAGAGGAGCCAACTCTAGTAAAATGTAGTGAGGCCATAATCCAAGGCAAAGTTTAACAAAT CTTGATTGTGTAATTTCTTATTCTGTTGATTCATTTTGTCACCCACCAGACTACCAAAAATAAAGCACAGACATGACAATTTTAGTATAT ACAACAGATTTGGCAAATAATACATAATCTTATTGTAATTGCCAGTAGCAATATCTTAAGGGGCATGAGTCTTTCACAGTATTGGACTTT GAAAAATTGGTACAGGGAGTAATTTTCAACAGACTGATACTTGAAGTCACTCAATTACTACTTTGACCTATCATAATTTGTTTCTAATCT TGTCATTTGCTCATATATACTATTAATATAACCAGTTGCTCTTTTCATAATGTACTATTTCTATGTAAAGATGTAAAGATTTTGATTTTC CTATGTTTTAAAATTGTAATGTGCATGATCTTTTATTTCTTGTGTTTCAATTACCAAGTCAGTATTCTAAGGTTGTAAGATTACTGTAAA AATTATATTCCAATATTTTATCTAAACTTAAGTGTGGCCAGCATTATTGGTTTCAGAGTTGCCTAAACAACACAGAATATCCTTAATTCA GTTTGTAAAAGAGTTTTGACCAGTGTAAAAAAGTGAAGACACAGTTTCATGTTTCAAGTTTAAAATGGAAAGTTAATATCATTTGAGCAC TTATGTGTTTTCATGTCTTCTACTTAATCTGTATGTGAAAGTAAAATATTTTTAACACCATTATTTATGCCATGTAAAGTGGGTTCTCAG AAGCACAAGCACAGATATTTACCTTCTGAAGACATTTTTGGCTATAAAAGTGCATTGGATGGCAAACACTATTTGAGTCAGGTGTTAGAA ATTTATTAGATGTATTATATTACATAGTAGAATAAGGTCCCTTTCTCATTTTGTTTTTCCTAAAAATAAGAAAAAAAAGAAGTGTGATAG TAAACTGTCTTTGCTAATGTCCTGCCAGATGTTTAACTTCAAATTAAGCAAAAAGTAGGTACAATATGATGATGATCCTGATGATGATGA TGATGATGATGATGAAGAATAAATGGAATCAAAATGCTAGCTTTATTTGACATTAATAAGTAAAATAAGTCATCATTTTTTCAACTCTGT AGCACAGCTGTTTACATTGAATAATTTTCTCTATTGTGCTGTTAATTATATAGTAATGTATCAAAATAGAAATAGGAACTTTCTTTTCAT TTCTTATTCATTTATGAAGAAATCTTTTCACACATAAATGATTGAATGTTCTTGTTCAGAATGACCACATAATCATTGCTTAGAAGAAGA TACCAATTCTTTTAAAAGAAAAAAAGTCTGTTTATAATAATCAGAATCAAATGTTGTTTGTTTCTTCTAAACGTTAATGGAGAAAATTGA AGGTGGTAAAATGTCATGTTTATTCAGGCTGGGAACTGTATTCACAGTAGAAGTTTCAGTGGTCAACATATCTATGACTCTTTAGGCTGC TGTAGTTTTACAGTCAATTATTTAAAAGTGAGTAGTTACATTTATAAGAGCCTGAGAATACTTAGACTCAGTCATTTGTTAGTATTTTTA CCAAAATCTCTTAGTTTCAGACATGTCAGAAGCAGCTATATAGCATATCTTATTCTATGATATACATCAGGCTATCTCAAGTTCCTGTCT CACAGTTAATTCAAAGAAGGATTAGGATTTCTGTATTTTTTCTCATTTGAATCTTTATGTGCATTTGGTTTGTGTACATGCTTTTTGTAG >In-frame_ENST00000310441_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=202AA_start in transcript=1014_stop in transcript=406 MQKHRWQVGGRHGRSHSSGKGCGGEKSTSGKGAPQFLSHTPFRLRQLSRRSGFSHSGRRLHGGRHLNCPPSLWLFPFFSLTPSPQEPPET VERLGSRSWRPLSPVAPTTCPGAPAYKLGREALGAAILSRLSLLPSSVVALPRRKWRSPGPVPTPPSPQHWPASGAGGKEPQAPRSSQPR -------------------------------------------------------------- >In-frame_ENST00000310441_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=1452nt_BP=1160nt CGGCTCCCAGGGAGGAGGCATGAGCGCCCTGCCGTTACCGCTTCTTCTGCCGTACAGTTGCCGCTTCGGGGCCTAACTCTAGCTCTTTGA AGCGGCTCCTGTGGGAAGGAGTCATAAGGCGGGAAGTGAGGATCGGACACCGCCTTGAGTTTGGTGTGCAGTGGAAGAACTGACCTAGGA GGAAGAGAATAGGGGGGAACGGGGAGCTAGTCTCAAGATGGCGGCTCCCACGGCGGCAGGCGCAGCCTGAGCAGCAGAGGCGGACTAAGG GGAGAGGCGCGAGACTTCACAAGCCGTACGGCGCGAGCCCCCAAACGGCCCTCGAGAGCTCGAGCTGGTTCCACCGGCCTCCGGCCCGCC TCCATTCGTTAGGTGTGTCGAGGCTGTTTCGGGAGCGGCGGCTGCACTAAGGCGCTGGGCGGGGAAGCGGGACGGTCTCAAGATGGCGGC TCCCACAATTGTGGTCTGAGCGCCGGCGGGGCTGCGACGACCGCGGCGCTTGTGGCTCCTTTCCACCCGCCCCGGAAGCCGGCCAGTGCT GGGGACTTGGGGGTGTGGGAACCGGGCCGGGGCTCCGCCATTTCCGGCGGGGGAGGGCTACGACTGAGGAAGGGAGGAGAGAGAGGCGGC TCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACTCAGCGGCCTCC AGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCAAAGGGAAGGAG GGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACGAAAGGGGGTGT GTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCCGTGTCGCCCGC CAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCACGGCCACCGCGC CGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACGGGGATTTGAGA CGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACGGAATGGTGCCA TTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAAAAAAAGGGGGA AAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGTATCCAGTTCTT >In-frame_ENST00000310441_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=202AA_start in transcript=1014_stop in transcript=406 MQKHRWQVGGRHGRSHSSGKGCGGEKSTSGKGAPQFLSHTPFRLRQLSRRSGFSHSGRRLHGGRHLNCPPSLWLFPFFSLTPSPQEPPET VERLGSRSWRPLSPVAPTTCPGAPAYKLGREALGAAILSRLSLLPSSVVALPRRKWRSPGPVPTPPSPQHWPASGAGGKEPQAPRSSQPR -------------------------------------------------------------- >In-frame_ENST00000369984_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=5194nt_BP=537nt AGGCGGCTCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACTCAGC GGCCTCCAGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCAAAGG GAAGGAGGGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACGAAAG GGGGTGTGTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCCGTGT CGCCCGCCAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCACGGCC ACCGCGCCGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACGGGGA TTTGAGACGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACGGAAT GGTGCCATTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAAAAAA AGGGGGAAAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGTATCC AGTTCTTAGTCCTTAGTCTTCATTTTTCATGAAGCAAACATATCTTGCATTAAAAGGGACATGAAGTTAGACATCATCTTAAGTTACAAC AACAGAATCCTTCCCACTACTTCTACAAAATTTTGTACATGAAATATATAATTATATAGCACTTTTATAGACTGAATTAAGGCAACCCCT TTCAAAACTTCCAGGGATCTACTTGAAAGGAAATGTTTTATAGCCATTTGTGAGCTAACAAAAGCTACAGTTTACTGAAGTTTACTTCAA GTCTTAATTGTCTACAAAAGTGTATTGAAGAGCAATATGATTAGATTATTTCTTAATAGATATCTTCTTTTGTAATTTTAAAATGCTGTT ACACAGCGTTAAGTTATAGAAACTAGTGTGTAAACATGTTGCTTGATCAAGAAAAAGTACAATACAGGGTGTATATTTATTTTTTGTGTT ATAAAGTTTACTTTTAGTTGCTCTTCTAGAGATTATTAGGTAATAAATGTGTATATACTGTATAATTTGCAATATACCCAGGAACTGATT TAAGATGGAATTGTGTGTGTGTTTGCTTGCACATGTGTGTGTTACCATTCTGCTTGCATTTCTAATAGTGTTTCAATTTTAGCAACATAT AGGAGCAAGTGTTCCAGAATGTAATATGAATAGGAGAAATAGGGAAGCAGTAAAACAAAATTTAACACAAGCTTGTGTCTCTTTTCCTCT CATGTGTCCAAAAGCTAATCTCTTTATTCACTAAAAGGAAATGTGTATAAGACTAAATCCCCTTTGGCTTTTTAAAAACATTTTGTGATA TCAGTGACAATGCAGTTCTTCTAGCCATTAATCTTGTACCCCTGTAAGAAATTTCACCTTTCTGAGTCCTGAAAAGTATCTTGTCAAGCA AAGTTGACACCGAAGGGCACATTTTCAGCAGGATGTAGAAGGATTTAACTGTGCAGGCTTCTGTTAATGTTGTTAAATCCAGGCACATAG CACGAAGCATCACCCTTAAGTGTTAATCCGTTGTAACCATTCCCATTTTGACTCAGTTCTAGAAATTTTGACTCTAAGGCAGCAATGGAA TTATGACAAATATATATATATACACATACACACACACAAATATATATATATGCTTATTTCCCTTCAGAATTTTATTTCAATAATTGATAA GTTTTATTTTTAATGGATGTTTATTCATTTGTTAATTTCAGTTTGTATTCAGTTACATGGCTTTGAGTTTATTTTATTGAACCAATCCAA GGTATTATGTAATTAGGCTTATTAAGGAATATAACATATCTTCTATGTATGCTCTATATACCACACATGATGAAGACTTATATTTGTGAT ACAAATTATGCAGTGTATTAGAAATTGTCCAAAACTGAGCTCCTGAGATAACCAACATTTTTGTATTATTACACTTTATAAAAATTATGG AATGTCATGTGATTAGTCAAAATCAGAGCATTTAAATAAAATACAGCCTACTCATGATTATCAATGTTAATAGTACAGTAGATCAGAGAA GCCTGGATTAATGAAATTTATCAGAAATATAGCCACGTTATATTAATGGTATTCTTTTTTCCAAGCACTTGTTTTATTTGAATATTAGCA CATATAAGAATAAACTTTTGGGAAATAACTACTTCCTATTCTGCCCACCCTTTACTTAAGCAGTAAAGTACCTCTTTTCTAAAGAACCAG GAAACATCAAAATAACCACAACAAAAATCTAAACAGTTTTCAAATAATACATTCAGTTCTCATAATAATAAGGGCTATATACCATGGGTC CACACAAACTGTGCTGCAAACATATAATCTATTAGTTTAGTAAAATTTCCAGAGATGTGAATTTAATATTTTCTTGATAAAATCATAAAA AAGCATCACCATTATTAAAGATGCATTTGTTCATTTCAATAAACAGAAATTAATGAAACAAATTACTTTTGTACAAAATAAATGATGATT ATGTGGCACTTTATTGAATTTTATAGAAATATTCCAATCTAAGTGATAAAGTAACAACTGAGAAACTTCAGAATGAAAGCCTTATTGATT CAAAAGGAAAATTACCATATGCTTTAGGGCTGATGAACTTGCCACAATTGCTTAGACATAACAAAGATATTTTCTACATTGTTTTCCAAC TTTATATGCTGAAAGATAATTAGGAGGTCCGGGTGGAGTGTATCTAAATGACTAGAACTTTAAGTTGCAATATAGATTTTCTCTTTTTAA CAAAGGAAGAATATAAATTAATTTGGATCAAATTTATTTGCCTTCTTTGCAATCTTGGTGATCATTTTGGAAAGTAAATTGAAAGGAAAG TTAAATAGCCACATAGTTTTCTTTTGCATCTCAATTTGGTTGAGAATTTCTAAGGAAGGTTAATATGACTTTAGAATGAATAAAGAGACT GTCAAACAACAAGTACTCTCCCTAAAAAAGAGGAAAGAATGCCTTCCTAAAATATTTGTTTCCTATTGTATATGTCACCAATTGGAAAAT GCCAATCTCATCTGCAAGTGTGAGAAATGGAACAAGGAGAGGAGCCAACTCTAGTAAAATGTAGTGAGGCCATAATCCAAGGCAAAGTTT AACAAATCTTGATTGTGTAATTTCTTATTCTGTTGATTCATTTTGTCACCCACCAGACTACCAAAAATAAAGCACAGACATGACAATTTT AGTATATACAACAGATTTGGCAAATAATACATAATCTTATTGTAATTGCCAGTAGCAATATCTTAAGGGGCATGAGTCTTTCACAGTATT GGACTTTGAAAAATTGGTACAGGGAGTAATTTTCAACAGACTGATACTTGAAGTCACTCAATTACTACTTTGACCTATCATAATTTGTTT CTAATCTTGTCATTTGCTCATATATACTATTAATATAACCAGTTGCTCTTTTCATAATGTACTATTTCTATGTAAAGATGTAAAGATTTT GATTTTCCTATGTTTTAAAATTGTAATGTGCATGATCTTTTATTTCTTGTGTTTCAATTACCAAGTCAGTATTCTAAGGTTGTAAGATTA CTGTAAAAATTATATTCCAATATTTTATCTAAACTTAAGTGTGGCCAGCATTATTGGTTTCAGAGTTGCCTAAACAACACAGAATATCCT TAATTCAGTTTGTAAAAGAGTTTTGACCAGTGTAAAAAAGTGAAGACACAGTTTCATGTTTCAAGTTTAAAATGGAAAGTTAATATCATT TGAGCACTTATGTGTTTTCATGTCTTCTACTTAATCTGTATGTGAAAGTAAAATATTTTTAACACCATTATTTATGCCATGTAAAGTGGG TTCTCAGAAGCACAAGCACAGATATTTACCTTCTGAAGACATTTTTGGCTATAAAAGTGCATTGGATGGCAAACACTATTTGAGTCAGGT GTTAGAAATTTATTAGATGTATTATATTACATAGTAGAATAAGGTCCCTTTCTCATTTTGTTTTTCCTAAAAATAAGAAAAAAAAGAAGT GTGATAGTAAACTGTCTTTGCTAATGTCCTGCCAGATGTTTAACTTCAAATTAAGCAAAAAGTAGGTACAATATGATGATGATCCTGATG ATGATGATGATGATGATGATGAAGAATAAATGGAATCAAAATGCTAGCTTTATTTGACATTAATAAGTAAAATAAGTCATCATTTTTTCA ACTCTGTAGCACAGCTGTTTACATTGAATAATTTTCTCTATTGTGCTGTTAATTATATAGTAATGTATCAAAATAGAAATAGGAACTTTC TTTTCATTTCTTATTCATTTATGAAGAAATCTTTTCACACATAAATGATTGAATGTTCTTGTTCAGAATGACCACATAATCATTGCTTAG AAGAAGATACCAATTCTTTTAAAAGAAAAAAAGTCTGTTTATAATAATCAGAATCAAATGTTGTTTGTTTCTTCTAAACGTTAATGGAGA AAATTGAAGGTGGTAAAATGTCATGTTTATTCAGGCTGGGAACTGTATTCACAGTAGAAGTTTCAGTGGTCAACATATCTATGACTCTTT AGGCTGCTGTAGTTTTACAGTCAATTATTTAAAAGTGAGTAGTTACATTTATAAGAGCCTGAGAATACTTAGACTCAGTCATTTGTTAGT ATTTTTACCAAAATCTCTTAGTTTCAGACATGTCAGAAGCAGCTATATAGCATATCTTATTCTATGATATACATCAGGCTATCTCAAGTT CCTGTCTCACAGTTAATTCAAAGAAGGATTAGGATTTCTGTATTTTTTCTCATTTGAATCTTTATGTGCATTTGGTTTGTGTACATGCTT >In-frame_ENST00000369984_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=129AA_start in transcript=648_stop in transcript=259 MKLQWHHSVYQLHLHFLKAVHDLLLVTDKSHSKPSQIPVLYTCSSSTIPSLPPPNTTMSSLMATARWPWRGRGTGPDQPTTRFQRGCRST -------------------------------------------------------------- >In-frame_ENST00000369984_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=829nt_BP=537nt AGGCGGCTCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACTCAGC GGCCTCCAGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCAAAGG GAAGGAGGGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACGAAAG GGGGTGTGTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCCGTGT CGCCCGCCAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCACGGCC ACCGCGCCGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACGGGGA TTTGAGACGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACGGAAT GGTGCCATTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAAAAAA AGGGGGAAAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGTATCC >In-frame_ENST00000369984_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=129AA_start in transcript=648_stop in transcript=259 MKLQWHHSVYQLHLHFLKAVHDLLLVTDKSHSKPSQIPVLYTCSSSTIPSLPPPNTTMSSLMATARWPWRGRGTGPDQPTTRFQRGCRST -------------------------------------------------------------- >In-frame_ENST00000354233_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=5378nt_BP=721nt AAGATGGCGGCTCCCACAATTGTGGTCTGAGCGCCGGCGGGGCTGCGACGACCGCGGCGCTTGTGGCTCCTTTCCACCCGCCCCGGAAGC CGGCCAGTGCTGGGGACTTGGGGGTGTGGGAACCGGGCCGGGGCTCCGCCATTTCCGGCGGGGGAGGGCTACGACTGAGGAAGGGAGGAG AGAGAGGCGGCTCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACT CAGCGGCCTCCAGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCA AAGGGAAGGAGGGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACG AAAGGGGGTGTGTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCC GTGTCGCCCGCCAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCAC GGCCACCGCGCCGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACG GGGATTTGAGACGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACG GAATGGTGCCATTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAA AAAAAGGGGGAAAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGT ATCCAGTTCTTAGTCCTTAGTCTTCATTTTTCATGAAGCAAACATATCTTGCATTAAAAGGGACATGAAGTTAGACATCATCTTAAGTTA CAACAACAGAATCCTTCCCACTACTTCTACAAAATTTTGTACATGAAATATATAATTATATAGCACTTTTATAGACTGAATTAAGGCAAC CCCTTTCAAAACTTCCAGGGATCTACTTGAAAGGAAATGTTTTATAGCCATTTGTGAGCTAACAAAAGCTACAGTTTACTGAAGTTTACT TCAAGTCTTAATTGTCTACAAAAGTGTATTGAAGAGCAATATGATTAGATTATTTCTTAATAGATATCTTCTTTTGTAATTTTAAAATGC TGTTACACAGCGTTAAGTTATAGAAACTAGTGTGTAAACATGTTGCTTGATCAAGAAAAAGTACAATACAGGGTGTATATTTATTTTTTG TGTTATAAAGTTTACTTTTAGTTGCTCTTCTAGAGATTATTAGGTAATAAATGTGTATATACTGTATAATTTGCAATATACCCAGGAACT GATTTAAGATGGAATTGTGTGTGTGTTTGCTTGCACATGTGTGTGTTACCATTCTGCTTGCATTTCTAATAGTGTTTCAATTTTAGCAAC ATATAGGAGCAAGTGTTCCAGAATGTAATATGAATAGGAGAAATAGGGAAGCAGTAAAACAAAATTTAACACAAGCTTGTGTCTCTTTTC CTCTCATGTGTCCAAAAGCTAATCTCTTTATTCACTAAAAGGAAATGTGTATAAGACTAAATCCCCTTTGGCTTTTTAAAAACATTTTGT GATATCAGTGACAATGCAGTTCTTCTAGCCATTAATCTTGTACCCCTGTAAGAAATTTCACCTTTCTGAGTCCTGAAAAGTATCTTGTCA AGCAAAGTTGACACCGAAGGGCACATTTTCAGCAGGATGTAGAAGGATTTAACTGTGCAGGCTTCTGTTAATGTTGTTAAATCCAGGCAC ATAGCACGAAGCATCACCCTTAAGTGTTAATCCGTTGTAACCATTCCCATTTTGACTCAGTTCTAGAAATTTTGACTCTAAGGCAGCAAT GGAATTATGACAAATATATATATATACACATACACACACACAAATATATATATATGCTTATTTCCCTTCAGAATTTTATTTCAATAATTG ATAAGTTTTATTTTTAATGGATGTTTATTCATTTGTTAATTTCAGTTTGTATTCAGTTACATGGCTTTGAGTTTATTTTATTGAACCAAT CCAAGGTATTATGTAATTAGGCTTATTAAGGAATATAACATATCTTCTATGTATGCTCTATATACCACACATGATGAAGACTTATATTTG TGATACAAATTATGCAGTGTATTAGAAATTGTCCAAAACTGAGCTCCTGAGATAACCAACATTTTTGTATTATTACACTTTATAAAAATT ATGGAATGTCATGTGATTAGTCAAAATCAGAGCATTTAAATAAAATACAGCCTACTCATGATTATCAATGTTAATAGTACAGTAGATCAG AGAAGCCTGGATTAATGAAATTTATCAGAAATATAGCCACGTTATATTAATGGTATTCTTTTTTCCAAGCACTTGTTTTATTTGAATATT AGCACATATAAGAATAAACTTTTGGGAAATAACTACTTCCTATTCTGCCCACCCTTTACTTAAGCAGTAAAGTACCTCTTTTCTAAAGAA CCAGGAAACATCAAAATAACCACAACAAAAATCTAAACAGTTTTCAAATAATACATTCAGTTCTCATAATAATAAGGGCTATATACCATG GGTCCACACAAACTGTGCTGCAAACATATAATCTATTAGTTTAGTAAAATTTCCAGAGATGTGAATTTAATATTTTCTTGATAAAATCAT AAAAAAGCATCACCATTATTAAAGATGCATTTGTTCATTTCAATAAACAGAAATTAATGAAACAAATTACTTTTGTACAAAATAAATGAT GATTATGTGGCACTTTATTGAATTTTATAGAAATATTCCAATCTAAGTGATAAAGTAACAACTGAGAAACTTCAGAATGAAAGCCTTATT GATTCAAAAGGAAAATTACCATATGCTTTAGGGCTGATGAACTTGCCACAATTGCTTAGACATAACAAAGATATTTTCTACATTGTTTTC CAACTTTATATGCTGAAAGATAATTAGGAGGTCCGGGTGGAGTGTATCTAAATGACTAGAACTTTAAGTTGCAATATAGATTTTCTCTTT TTAACAAAGGAAGAATATAAATTAATTTGGATCAAATTTATTTGCCTTCTTTGCAATCTTGGTGATCATTTTGGAAAGTAAATTGAAAGG AAAGTTAAATAGCCACATAGTTTTCTTTTGCATCTCAATTTGGTTGAGAATTTCTAAGGAAGGTTAATATGACTTTAGAATGAATAAAGA GACTGTCAAACAACAAGTACTCTCCCTAAAAAAGAGGAAAGAATGCCTTCCTAAAATATTTGTTTCCTATTGTATATGTCACCAATTGGA AAATGCCAATCTCATCTGCAAGTGTGAGAAATGGAACAAGGAGAGGAGCCAACTCTAGTAAAATGTAGTGAGGCCATAATCCAAGGCAAA GTTTAACAAATCTTGATTGTGTAATTTCTTATTCTGTTGATTCATTTTGTCACCCACCAGACTACCAAAAATAAAGCACAGACATGACAA TTTTAGTATATACAACAGATTTGGCAAATAATACATAATCTTATTGTAATTGCCAGTAGCAATATCTTAAGGGGCATGAGTCTTTCACAG TATTGGACTTTGAAAAATTGGTACAGGGAGTAATTTTCAACAGACTGATACTTGAAGTCACTCAATTACTACTTTGACCTATCATAATTT GTTTCTAATCTTGTCATTTGCTCATATATACTATTAATATAACCAGTTGCTCTTTTCATAATGTACTATTTCTATGTAAAGATGTAAAGA TTTTGATTTTCCTATGTTTTAAAATTGTAATGTGCATGATCTTTTATTTCTTGTGTTTCAATTACCAAGTCAGTATTCTAAGGTTGTAAG ATTACTGTAAAAATTATATTCCAATATTTTATCTAAACTTAAGTGTGGCCAGCATTATTGGTTTCAGAGTTGCCTAAACAACACAGAATA TCCTTAATTCAGTTTGTAAAAGAGTTTTGACCAGTGTAAAAAAGTGAAGACACAGTTTCATGTTTCAAGTTTAAAATGGAAAGTTAATAT CATTTGAGCACTTATGTGTTTTCATGTCTTCTACTTAATCTGTATGTGAAAGTAAAATATTTTTAACACCATTATTTATGCCATGTAAAG TGGGTTCTCAGAAGCACAAGCACAGATATTTACCTTCTGAAGACATTTTTGGCTATAAAAGTGCATTGGATGGCAAACACTATTTGAGTC AGGTGTTAGAAATTTATTAGATGTATTATATTACATAGTAGAATAAGGTCCCTTTCTCATTTTGTTTTTCCTAAAAATAAGAAAAAAAAG AAGTGTGATAGTAAACTGTCTTTGCTAATGTCCTGCCAGATGTTTAACTTCAAATTAAGCAAAAAGTAGGTACAATATGATGATGATCCT GATGATGATGATGATGATGATGATGAAGAATAAATGGAATCAAAATGCTAGCTTTATTTGACATTAATAAGTAAAATAAGTCATCATTTT TTCAACTCTGTAGCACAGCTGTTTACATTGAATAATTTTCTCTATTGTGCTGTTAATTATATAGTAATGTATCAAAATAGAAATAGGAAC TTTCTTTTCATTTCTTATTCATTTATGAAGAAATCTTTTCACACATAAATGATTGAATGTTCTTGTTCAGAATGACCACATAATCATTGC TTAGAAGAAGATACCAATTCTTTTAAAAGAAAAAAAGTCTGTTTATAATAATCAGAATCAAATGTTGTTTGTTTCTTCTAAACGTTAATG GAGAAAATTGAAGGTGGTAAAATGTCATGTTTATTCAGGCTGGGAACTGTATTCACAGTAGAAGTTTCAGTGGTCAACATATCTATGACT CTTTAGGCTGCTGTAGTTTTACAGTCAATTATTTAAAAGTGAGTAGTTACATTTATAAGAGCCTGAGAATACTTAGACTCAGTCATTTGT TAGTATTTTTACCAAAATCTCTTAGTTTCAGACATGTCAGAAGCAGCTATATAGCATATCTTATTCTATGATATACATCAGGCTATCTCA AGTTCCTGTCTCACAGTTAATTCAAAGAAGGATTAGGATTTCTGTATTTTTTCTCATTTGAATCTTTATGTGCATTTGGTTTGTGTACAT >In-frame_ENST00000354233_ENST00000273854_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=129AA_start in transcript=832_stop in transcript=443 MKLQWHHSVYQLHLHFLKAVHDLLLVTDKSHSKPSQIPVLYTCSSSTIPSLPPPNTTMSSLMATARWPWRGRGTGPDQPTTRFQRGCRST -------------------------------------------------------------- >In-frame_ENST00000354233_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(transcript)=1013nt_BP=721nt AAGATGGCGGCTCCCACAATTGTGGTCTGAGCGCCGGCGGGGCTGCGACGACCGCGGCGCTTGTGGCTCCTTTCCACCCGCCCCGGAAGC CGGCCAGTGCTGGGGACTTGGGGGTGTGGGAACCGGGCCGGGGCTCCGCCATTTCCGGCGGGGGAGGGCTACGACTGAGGAAGGGAGGAG AGAGAGGCGGCTCAAGATGGCGGCTCCCAGGGCCTCCCGCCCGAGCTTGTAAGCGGGAGCGCCCGGACAAGTAGTCGGGGCGACGGGACT CAGCGGCCTCCAGCTTCTTGAGCCTAGGCGCTCGACAGTTTCGGGCGGCTCTTGCGGAGACGGGGTGAGCGAGAAGAAAGGGAAGAGCCA AAGGGAAGGAGGGCAGTTAAGATGGCGGCCTCCATGGAGTCGTCTACCGCTGTGTGAGAAACCGCTTCTCCGTGAGAGCTGCCTTAGACG AAAGGGGGTGTGTGAAAGGAATTGAGGGGCTCCCTTCCCGCTTGTTGACTTCTCCCCACCGCACCCTTTCCCGGAACTATGGCTTCGGCC GTGTCGCCCGCCAACTTGCCAGCGGTGCTTCTGCAGCCCCGCTGGAAGCGAGTGGTGGGCTGGTCGGGTCCGGTGCCACGGCCCCGCCAC GGCCACCGCGCCGTGGCCATCAAGGAGCTCATCGTGGTGTTTGGCGGCGGCAACGAGGGAATAGTGGACGAACTGCACGTGTACAACACG GGGATTTGAGACGGCTTGGAGTGACTCTTGTCGGTCACCAGAAGAAGATCATGAACAGCCTTCAAGAAATGAAGGTGCAGCTGGTAAACG GAATGGTGCCATTGTAACTTCATGTAAATGTCGCTTCTTCAAGTGAATGATTCTGCACTTTGTAAACAGCACTGAGATTTATTTTAACAA AAAAAGGGGGAAAAGGGAAAACAGTGATTTCTAAACCTTAGAAAACATTTGCCTCAGCCACAGAATTTGTAATCATGGTTTTACTGAAGT >In-frame_ENST00000354233_ENST00000354839_TCGA-LA-A446-01A_HCFC1_chrX_153236099_-_EPHA5_chr4_66189937_length(amino acids)=129AA_start in transcript=832_stop in transcript=443 MKLQWHHSVYQLHLHFLKAVHDLLLVTDKSHSKPSQIPVLYTCSSSTIPSLPPPNTTMSSLMATARWPWRGRGTGPDQPTTRFQRGCRST -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for HCFC1-EPHA5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 813_912 | 64.33333333333333 | 2036.0 | GABP2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 813_912 | 64.33333333333333 | 1967.0 | GABP2 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 610_722 | 64.33333333333333 | 2036.0 | SIN3A |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 610_722 | 64.33333333333333 | 1967.0 | SIN3A |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000310441 | - | 1 | 26 | 750_902 | 64.33333333333333 | 2036.0 | ZBTB17 |
Hgene | HCFC1 | chrX:153236099 | chr4:66189937 | ENST00000354233 | - | 1 | 27 | 750_902 | 64.33333333333333 | 1967.0 | ZBTB17 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for HCFC1-EPHA5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | EPHA5 | P54756 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | EPHA5 | P54756 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | EPHA5 | P54756 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | EPHA5 | P54756 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | EPHA5 | P54756 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | EPHA5 | P54756 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | EPHA5 | P54756 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | EPHA5 | P54756 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | EPHA5 | P54756 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | EPHA5 | P54756 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for HCFC1-EPHA5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | HCFC1 | C0796208 | MENTAL RETARDATION, X-LINKED 3 | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | HCFC1 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | HCFC1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | HCFC1 | C2931498 | Mental Retardation, X-Linked 1 | 1 | ORPHANET |